Brinter takes its 3D bioprinter on a European road show
Stopping in Estonia, Germany and Poland, participants are invited to bring their own materials to test out the Brinter One’s functionality for use cases that range from personalized drugs to human spare parts.
Finnish 3D bioprinting scaleup Brinter is taking its modular 3D bioprinter on a European road trip this week, stopping in Estonia, Germany, and Poland. The printer’s first stop is at the University of Tartu on November 12th.
On its tour, Brinter will do live demonstrations of bioprinting and thermoplastic printing. The aim of the roadshow is to showcase the advanced practical application possibilities of the technology, and give people hands-on experience with premium 3D bioprinters.
“We are excited to hit the road and show people what our Brinters can really achieve – after all, we purposefully designed them to be easily usable even though having very advanced features. What better way to do that than a roadshow?” says Tomi Kalpio, CEO of Brinter.
Additionally, interested participants can bring their own materials to test out the Brinter One’s multi-material print heads – capable of intricate tissue engineering and cell therapy, such as repairing damaged tissue, replacing lost biological functions, and localized therapeutic solutions for the treatment of disease. For example, the new multifluidics print head can recreate the precise architecture of human tissue using multiple materials and dispense a combination of various materials in the same print job using microfluidic manipulation.
“We want to show how easy it is to recreate the precise architecture of human tissue using multiple materials and dispense a combination of various materials in the same print job using our Brinters,” continues Kalpio.
“The printing of functional human spare parts such as hearts, kidneys, bionic limbs, even brains, is closer than we think, and we want to demonstrate how our tools that can help achieve this – even when operating under tight budget restrictions,” he concludes.
Brinter’s flagship model Brinter One is a modular bioprinter that is able to print multi-material and highly complex tissue structures in 3D, providing all the basic features needed for bioprinting. The device can print both stiff and soft materials, including but not limited to liquids and hydrogels with living cells, bio-paste, metal with a binder material, and plastic.
Due to the device’s modularity, it is possible to make modifications to the hardware to accommodate the combinations needed, such as temperature control or imaging options. Without this modular approach, new devices would need to be bought for every function like granulate, paste extrusion, fluidic manipulation or liquid dispensing.
To date, Brinter is currently active in over 10 countries, including the USA, Germany, India, and the UK. Customers of Brinter include bio and pharmaceutical companies like Bayer and Nanoform, as well as research organizations like VTT, BEST group at the University of Glasgow, Johannes Gutenberg University of Mainz, the University of Oulu, University of Turku, Åbo Akademi, Tampere University, and the University of Helsinki.
Roadshow tour dates and locations
Nov 12th: Estonia – University of Tartu
Nov 15th-18th: Germany – Formnext 2022 Event, Frankfurt am Main
Nov 21st: Germany – Johannes Gutenberg University
Nov 22nd: Germany – University of Technology, Berlin, Institute of Biotechnology (to be confirmed)
Nov 25th: Poland – Bioprinting workshop, Adam Mickiewicz University, Poznan
To book a free demo with the Brinter team, contact:
Pasi Kaskinen
Sales and Marketing Director, Brinter
+358 50 575 7577
###
For additional information:
Media kit with pictures
About Brinter
Founded in 2020 via partial demerger in Turku, Finland, Brinter is a trailblazing Finnish bioprinting company providing comprehensive 3D bioprinting solutions and services for pharmaceutical, biotechnological and cosmetic industries, universities, and research facilities. Brinter is a modular multi-material bioprinting platform scalable from manual R&D to automated production. The company works with science and bioengineering organizations to integrate 3D bioprinting into their research, manufacturing, and treatment methods. The goal is to break through current technological limitations and improve people’s quality of life. For more information, visit www.brinter.com.
